There is an urgent need to establish blood biomarkers for Alzheimer's disease (AD).
Although it has been speculated that brain-derived neurotrophic factor (BDNF) is associated …

Alzheimer's disease (AD) is characterized by cognitive decline and loss of neurons in
specific brain regions. Recent findings have suggested an involvement of brain-derived …

Deregulation of brain-derived neurotrophic factor (BDNF) is a possible contributor to the
pathology and symptoms of Alzheimer's disease (AD). Most studies support an association …

The neurotrophin brain-derived neurotrophic factor (BDNF) plays a critical role in neuronal
survival, synaptic plasticity, and memory. Several recent studies have demonstrated altered …

There is little information on the dynamics of BDNF in the CSF in the continuum between
healthy aging, MCI and AD. We included 128 older adults (77 with amnestic MCI, 26 with AD …

The current search for biomarkers that are diagnostic and/or prognostic of Alzheimer's
disease (AD) is of vital importance given the rapidly aging population. It was recently …

Background Brain-derived neurotrophic factor (BDNF) is an activity-dependent secreted
protein that is critical to organization of neuronal networks and synaptic plasticity, especially …

Mounting evidence that alterations in brain-derived neurotrophic factor (BDNF) levels and
signaling may be involved in the etiopathogenesis of Alzheimer's disease (AD) has …

Findings from previous studies reporting the levels of serum brain-derived neurotrophic
factor (BDNF) in patients with Alzheimer's disease (AD) and individuals with mild cognitive …

Alzheimer's disease (AD) is becoming a growing global problem, and there is an urgent
need to identify reliable blood biomarkers of the risk and progression of this condition. A …